文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

2019年冠状病毒病：对系统性红斑狼疮患者护理与管理的启示

Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus.

作者信息

Sawalha Amr H, Manzi Susan

机构信息

Division of Rheumatology, Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

出版信息

Eur J Rheumatol. 2020 Aug;7(Suppl 2):S117-S120. doi: 10.5152/eurjrheum.2020.20055. Epub 2020 Apr 8.

DOI:10.5152/eurjrheum.2020.20055
PMID:32352359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7431343/
Abstract

Systemic lupus erythematosus is a chronic remitting-relapsing autoimmune disease that affects multiple organ systems. In this article we discuss aspects in the management of lupus patients that are particularly relevant during the current SARS-CoV-2 pandemic. We speculate that lupus patients might be more susceptible for a more severe COVID-19 disease course and emphasize the importance of maintaining remission in lupus patients. We discuss the critical role hydroxychloroquine plays in the management of lupus patients and suggest considering the psychosocial implications of the current pandemic on lupus care.

摘要

系统性红斑狼疮是一种影响多个器官系统的慢性缓解-复发型自身免疫性疾病。在本文中，我们讨论了在当前新型冠状病毒肺炎大流行期间，狼疮患者管理中特别相关的方面。我们推测狼疮患者可能更容易患更严重的新型冠状病毒肺炎病程，并强调维持狼疮患者缓解的重要性。我们讨论了羟氯喹在狼疮患者管理中所起的关键作用，并建议考虑当前大流行对狼疮护理的社会心理影响。

相似文献

[1]
Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus.

Eur J Rheumatol. 2020-8

[2]
Disease course patterns in systemic lupus erythematosus.

Lupus. 2019-1

[3]
Evaluation of Mental Health Factors among People with Systemic Lupus Erythematosus during the SARS-CoV-2 Pandemic.

J Clin Med. 2020-9-5

[4]
[Hazard of acquired long QT syndrome during coronavirus pandemic. Focus on hydroxychloroquine].

Orv Hetil. 2020-4-1

[5]
Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.

J Rheumatol. 2020-6-1

[6]
Response to 'To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic' by Parperis.

Ann Rheum Dis. 2021-1

[7]
Systemic Lupus Erythematosus and Coronavirus Disease 2019.

Rheumatol Immunol Res. 2021-4-13

[8]
[Juvenile systemic lupus erythematosus with unusual manifestation of lupus-associated panniculitis].

Hautarzt. 2015-10

[9]
Factors Related to Knowledge, Perception, and Practices Towards COVID-19 Among Patients with Autoimmune Diseases: A Multicenter Online Survey.

Acta Med Indones. 2020-7

[10]
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic.

Ann Rheum Dis. 2021-1

引用本文的文献

[1]
The role of vitamin D in pediatric systemic lupus erythematosus - a double pawn in the immune and microbial balance.

Front Immunol. 2024

[2]
Psychosocial impact of SARS- CoV-2 outbreak on patients with pediatric-onset systemic lupus erythematosus and their caregivers.

J Family Med Prim Care. 2022-12

[3]
Systemic Lupus Erythematosus and Coronavirus Disease 2019.

Rheumatol Immunol Res. 2021-4-13

[4]
Immunogenicity and Safety of mRNA Anti-SARS-CoV-2 Vaccines in Patients with Systemic Lupus Erythematosus.

Vaccines (Basel). 2022-7-30

[5]
ACT for Lupus: Pilot Feasibility and Acceptability Study of a Novel Web-Based Acceptance and Commitment Therapy Program for Patients With Lupus.

ACR Open Rheumatol. 2022-7

[6]
Toxic Epidermal Necrolysis-Like Lupus Erythematous Presentation Following SARS-CoV-2 Infection.

J Med Cases. 2022-2

[7]
Poor Prognosis of COVID-19 Acute Respiratory Distress Syndrome in Lupus Erythematosus: Nationwide Cross-Sectional Population Study Of 252 119 Patients.

ACR Open Rheumatol. 2021-11

[8]
Autoimmune connective tissue diseases in the COVID-19 pandemic.

Clin Dermatol. 2021

[9]
Systemic lupus erythematosus and varicella-like rash following COVID-19 in a previously healthy patient.

J Med Virol. 2021-5

[10]
SARS-CoV-2 and Systemic Lupus Erythematosus.

Curr Rheumatol Rep. 2021-1-28

本文引用的文献

[1]
Effective treatment of severe COVID-19 patients with tocilizumab.

Proc Natl Acad Sci U S A. 2020-4-29

[2]
Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients.

Clin Immunol. 2020-4-8

[3]
High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019.

Open Forum Infect Dis. 2020-3-21

[4]
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020.

MMWR Morb Mortal Wkly Rep. 2020-4-3

[5]
A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19.

Ann Intern Med. 2020-3-30

[6]
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.

Int J Antimicrob Agents. 2020-3-20

[7]
Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic.

Liver Transpl. 2020-6

[8]
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro.

Cell Discov. 2020-3-18

[9]
Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study.

World J Pediatr. 2020-3-19

[10]
COVID-19: consider cytokine storm syndromes and immunosuppression.

Lancet. 2020-3-28

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索